☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
|
90-0199783
|
(State or other jurisdiction of incorporation or organization)
|
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
1275 Market Street
|
San Francisco
|
California
|
94103-1410
|
(Address of principal executive offices)
|
|
|
(Zip Code)
|
Securities registered pursuant to Section 12(b) of the Act:
|
||
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Class A common stock, $0.001 par value
|
DLB
|
The New York Stock Exchange
|
Securities registered pursuant to Section 12(g) of the Act:
|
||
Title of each class
|
|
|
Class B common stock, $0.001 par value
|
|
|
PART I
|
|||
Item 1
|
—
|
||
Item 1A
|
—
|
||
Item 1B
|
—
|
||
Item 2
|
—
|
||
Item 3
|
—
|
||
Item 4
|
—
|
||
|
|
|
|
PART II
|
|||
Item 5
|
—
|
||
Item 6
|
—
|
||
Item 7
|
—
|
||
Item 7A
|
—
|
||
Item 8
|
—
|
Consolidated Financial Statements
|
|
Item 9
|
—
|
||
Item 9A
|
—
|
||
Item 9B
|
—
|
||
|
|
|
|
PART III
|
|||
Item 10
|
—
|
||
Item 11
|
—
|
||
Item 12
|
—
|
||
Item 13
|
—
|
||
Item 14
|
—
|
||
|
|
|
|
PART IV
|
|||
Item 15
|
—
|
||
Item 16
|
—
|
||
Abbreviation
|
|
Term
|
AAC
|
|
Advanced Audio Coding
|
AFS
|
|
Available-For-Sale (Securities)
|
AOCI
|
|
Accumulated Other Comprehensive Income
|
APIC
|
|
Additional-Paid In-Capital
|
ASC
|
|
Accounting Standards Codification
|
ASP
|
|
Average Selling Price
|
ASU
|
|
Accounting Standards Update
|
ATSC
|
|
Advanced Television Systems Committee
|
AVC
|
|
Advanced Video Coding
|
AVR
|
|
Audio/Video Receiver
|
CE
|
|
Consumer Electronics
|
CES
|
|
Consumer Electronics Show
|
CODM
|
|
Chief Operating Decision Maker
|
COGS
|
|
Cost Of Goods Sold
|
COSO
|
|
Committee Of Sponsoring Organizations (Of The Treadway Commission)
|
DD
|
|
Dolby Digital®
|
DD+
|
|
Dolby Digital Plus™
|
DMA
|
|
Digital Media Adapter
|
DTV
|
|
Digital Television
|
DVB
|
|
Digital Video Broadcasting
|
DVD
|
|
Digital Versatile Disc
|
EPS
|
|
Earnings Per Share
|
ESP
|
|
Estimated Selling Price
|
ESPP
|
|
Employee Stock Purchase Plan
|
FASB
|
|
Financial Accounting Standards Board
|
FCPA
|
|
Foreign Corrupt Practices Act
|
G&A
|
|
General & Administrative
|
HD
|
|
High Definition
|
HDR
|
|
High-Dynamic Range
|
HDTV
|
|
High Definition Television
|
HE-AAC
|
|
High Efficiency Advanced Audio Coding
|
HEVC
|
|
High Efficiency Video Coding
|
HFR
|
|
High Frame Rate
|
HTIB
|
|
Home Theater In-A-Box
|
IC
|
|
Integrated Circuit
|
IP
|
|
Intellectual Property
|
IPO
|
|
Initial Public Offering
|
IPTV
|
|
Internet Protocol Television
|
IT
|
|
Information Technology
|
LP
|
|
Limited Partner/Partnership
|
NOL
|
|
Net Operating Loss
|
OCI
|
|
Other Comprehensive Income
|
ODD
|
|
Optical Disc Drive
|
OECD
|
|
Organization For Economic Co-Operation & Development
|
OEM
|
|
Original Equipment Manufacturer
|
OTT
|
|
Over-The-Top
|
PC
|
|
Personal Computer
|
PCS
|
|
Post-Contract Support
|
PP&E
|
|
Property, Plant, & Equipment
|
PSO
|
|
Performance-Based Stock Option
|
R&D
|
|
Research & Development
|
RSU
|
|
Restricted Stock Unit
|
S&M
|
|
Sales & Marketing
|
SERP
|
|
Supplemental Executive Retirement Plan
|
SoC
|
|
System(s)-On-A-Chip
|
SSP
|
|
Standalone selling price
|
STB
|
|
Set-Top Box
|
TPE
|
|
Third Party Evidence
|
TSR
|
|
Total Stockholder Return
|
UHD
|
|
Ultra High Definition
|
U.S. GAAP
|
|
Generally Accepted Accounting Principles In The United States
|
VSOE
|
|
Vendor Specific Objective Evidence
|
|
Fiscal Year Ended
|
||
Revenue
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
Licensing
|
89%
|
89%
|
89%
|
Products and services
|
11%
|
11%
|
11%
|
Total
|
100%
|
100%
|
100%
|
Technology
|
Description
|
AAC & HE-AAC
|
An advanced digital audio codec solution with higher bandwidth efficiency used for a wide range of media applications.
|
AVC
|
A digital video codec with high bandwidth efficiency used in a wide range of media devices.
|
Dolby® AC-4
|
A next-generation digital audio coding technology that increases transmission efficiency while delivering new audio experiences, including Dolby Atmos, to a wide range of playback devices.
|
Dolby Atmos®
|
An object-oriented audio technology for cinema and a wide range of media devices that allows sound to be precisely placed and moved anywhere in the listening environment including the overhead dimension. Dolby Atmos is an immersive experience that can be provided via multiple Dolby audio coding technologies.
|
Dolby Digital®
|
A digital audio coding technology that provides multichannel sound to a variety of media applications.
|
Dolby Digital Plus™
|
An advanced digital audio coding technology that offers more efficient audio transmission for a wide range of media applications and devices.
|
Dolby® TrueHD
|
A digital audio coding technology providing lossless encoding for premium quality media applications.
|
Dolby Vision®
|
An imaging technology combining high dynamic range and dynamic metadata to deliver higher color contrast, brighter contrast, and improved details for cinema and a wide range of media devices.
|
Dolby Voice®
|
An audio conferencing technology with superior spatial perception, voice clarity, and background noise reduction that emulates the in-person meeting experience.
|
HEVC
|
A next-generation digital video codec with high bandwidth efficiency to support ultra-high definition experiences for a wide range of media devices.
|
|
Fiscal Year Ended
|
|
||
Market
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
Main Offerings Incorporating Our Technologies
|
Broadcast
|
43%
|
41%
|
44%
|
STBs & Televisions
|
Mobile
|
17%
|
16%
|
15%
|
Smartphones & Tablets
|
CE
|
14%
|
15%
|
13%
|
DMAs, Blu-ray Disc devices, AVRs, Soundbars, DVDs, & HTIBs
|
PC
|
10%
|
11%
|
13%
|
Windows and macOS operating systems
|
Other
|
16%
|
17%
|
15%
|
Gaming consoles, Auto DVD, Dolby Cinema, & Dolby Voice
|
Total
|
100%
|
100%
|
100%
|
|
Product
|
Description
|
|
Cinema
|
Cinema Imaging Products
|
Digital Cinema Servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode, and package digital media files for distribution.
|
Cinema Audio Products
|
Cinema Processors, amplifiers, and loudspeakers used to decode, render, and optimally playback digital cinema soundtracks including those using Dolby Atmos.
|
|
Other
|
Dolby Conference Phone
|
An integral hardware component of the Dolby Voice conferencing solution that enhances full-room voice capture, spatial voice separation, and playback.
|
Dolby Voice Room
|
Video conferencing solution for huddle rooms and small conference rooms that combines a camera product with the Dolby Conference Phone and Dolby Voice technology.
|
|
Other Products
|
3-D glasses and kits, broadcast hardware and software used to encode, transmit, and decode multiple channels of high quality audio for DTV and HDTV distribution, monitors, and accessibility solutions for hearing and visually impaired consumers.
|
•
|
DD+ and HE-AAC are mandated for use in terrestrial broadcast across many countries including France, Italy, the United Kingdom, Sweden, Germany, Poland, Turkey, and Russia. In addition, DD+ and HE-AAC are included in the digital terrestrial television specifications of emerging digital TV markets in Africa, South-East Asia, and India while operators in China have selected DD and DD+ as optional technologies for transmissions using the country’s digital terrestrial television specification. In mobile devices, HE-AAC is specified for various applications in the 3GPP suite of standards, and is a de facto audio standard in entertainment services.
|
•
|
DD+ is the de facto technology used by a wide range of pay-TV operators and streaming services worldwide and is included in popular operating systems such as iOS and Windows. It is also widely used by major OTT services such as Apple TV, Netflix, and Amazon, and is included in the specifications of these services.
|
•
|
DD is mandated for HD broadcast in multiple regions including North America and South Korea, and for DVD players on a global basis.
|
•
|
AC-4 is Dolby’s next generation of audio coding technology that has been adopted for implementation in certain regions by worldwide standards organizations including the DVB and ATSC. AC-4 has also been adopted or proposed in forthcoming regional and country standards in North America and Europe. The transition for AC-4 continues to gain momentum, and is already being supported in a number of TVs that are available worldwide from major manufacturers.
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Research & Development
|
$
|
237,871
|
|
$
|
236,794
|
|
$
|
233,312
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Sales & Marketing
|
$
|
343,835
|
|
$
|
309,762
|
|
$
|
296,661
|
|
•
|
Degree of access and inclusion in industry standards;
|
•
|
Technological performance, flexibility, and range of application;
|
•
|
Brand recognition and reputation;
|
•
|
Timeliness and relevance of new product introductions;
|
•
|
Quality and reliability of products and services;
|
•
|
Relationships with producers, directors, and distributors in the film industry, with television broadcast industry leaders, with OTT industry leaders, and with the management of semiconductor and consumer electronics OEMs;
|
•
|
Availability of compatible high quality audio and video content; and
|
•
|
Price.
|
•
|
Royalty reports including positive or negative corrective adjustments;
|
•
|
Retroactive royalties that cover extended periods of time; and
|
•
|
Timing of revenue recognition under licensing agreements and other contractual arrangements, including recognition of unusually large amounts of revenue in any given quarter.
|
•
|
Rapid technological change;
|
•
|
New and improved technology and frequent product introductions;
|
•
|
Changing consumer and licensee demands;
|
•
|
Evolving industry standards; and
|
•
|
Technology and product obsolescence.
|
•
|
Possibility that innovations may not be protectable;
|
•
|
Failure to protect innovations that later turn out to be important;
|
•
|
Insufficient patent protection to prevent third parties from designing around our patent claims;
|
•
|
Our pending patent applications may not be approved; and
|
•
|
Possibility that an issued patent may later be found to be invalid or unenforceable.
|
•
|
Our ability to enforce our contractual and IP rights, especially in countries that do not recognize and enforce IP rights to the same extent as the U.S., Japan, Korea, and European countries do, which increases the risk of unauthorized use of our technologies;
|
•
|
Limited or no patent protection for our DD technologies in countries such as China, Taiwan, and India, which may require us to obtain patent rights for new and existing technologies in order to grow or maintain our revenue; and
|
•
|
Because of limitations in the legal systems in many countries, our ability to obtain and enforce patents in many countries is uncertain, and we must strengthen and develop relationships with entertainment industry participants worldwide to increase our ability to enforce our IP and contractual rights without relying solely on the legal systems in the countries in which we operate.
|
•
|
Content creators, such as film directors, studios, mobile and online content producers, and music producers;
|
•
|
Content distributors, such as studios, film exhibitors, broadcasters, operators, and OTT video service providers and video game publishers;
|
•
|
Leading companies in the audio and video conferencing markets; and
|
•
|
Device manufacturers.
|
•
|
Diversion of management time and focus from operating our business to acquisition integration challenges;
|
•
|
Cultural and logistical challenges associated with integrating employees from acquired businesses into our organization;
|
•
|
Retaining employees, suppliers and customers from businesses we acquire;
|
•
|
The need to implement or improve internal controls, procedures, and policies appropriate for a public company at businesses that prior to the acquisition may have lacked effective controls, procedures, and policies;
|
•
|
Possible write-offs or impairment charges resulting from acquisitions;
|
•
|
Unanticipated or unknown liabilities relating to acquired businesses; and
|
•
|
The need to integrate acquired businesses’ accounting, management information, manufacturing, human resources, and other administrative systems to permit effective management.
|
•
|
U.S. and foreign government trade restrictions, including those which may impose restrictions on the importation of programming, technology, or components to or from the U.S., and those which may put restrictions or prohibitions on the exportation, reexportation, sale, shipment or other transfer of programming, technology, components, and/or services to foreign persons;
|
•
|
Changes in trade relationships, including new tariffs, trade protection measures, import or export licensing requirements, trade embargoes and other trade barriers;
|
•
|
Tariffs imposed by the U.S. on goods from other countries or tariffs imposed by other countries on U.S. goods, including the tariffs imposed over the course of 2018 and 2019 by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods, the scope and duration of which remain uncertain;
|
•
|
Compliance with applicable international laws and regulations, including antitrust and other competition laws, that may change unexpectedly, differ, or conflict with laws in other countries where we conduct business, or are otherwise not harmonized with one another;
|
•
|
Foreign government taxes, regulations, and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the U.S., and other laws limiting our ability to repatriate funds to the U.S.;
|
•
|
Potential adverse changes in the political and/or economic stability of foreign countries or in their diplomatic relations with the U.S.;
|
•
|
Difficulty in establishing, staffing, and managing foreign operations, including but not limited to restrictions on the ability to obtain or retain licenses required for operation, relationships with local labor unions and works councils, investment restrictions and/or requirements, and restrictions on foreign ownership of subsidiaries;
|
•
|
Adverse fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake;
|
•
|
Poor recognition of IP rights;
|
•
|
Difficulties in enforcing contractual rights;
|
•
|
Multi-jurisdictional data protection and privacy laws, including the European Union's General Data Protection Regulation and restrictions on transferring personally identifiable information outside of a jurisdiction;
|
•
|
Political or social instability in the U.K. and Europe (including but not limited to uncertainty resulting from the Brexit referendum in the U.K.) and in Russia, the Middle East, North Africa, Latin America and other emerging markets;
|
•
|
Uncertainties related to any geopolitical, economic and regulatory effects or changes due to the current political climate in the U.S.;
|
•
|
Natural disasters, war or events of terrorism; and
|
•
|
The global macroeconomic environment and potential slowing of key markets we serve, such as the current economic challenges in China.
|
•
|
Changes in geographic mix of earnings, where earnings are lower than anticipated in countries with lower tax rates and higher than anticipated in countries with higher tax rates;
|
•
|
Changes in the valuation of our deferred tax assets and liabilities;
|
•
|
Changes in transfer pricing arrangements;
|
•
|
Outcomes of tax audits;
|
•
|
Changes in accounting principles; or
|
•
|
Changes in tax laws and regulations in the countries in which we operate, including an increase in tax rates, or an adverse change in the treatment of an item of income or expense.
|
Entity Name
|
Minority Ownership Interest
|
Location Of Properties
|
Approximate Square Footage
|
Dolby Properties Brisbane, LLC
|
49.0%
|
Brisbane, California
|
43,500
|
Dolby Properties Burbank, LLC
|
49.0%
|
Burbank, California
|
22,000
|
Dolby Properties, LP
|
10.0%
|
Wootton Bassett, England
|
17,500
|
Authorization Period
|
Authorization Amount
|
||
Fiscal 2010: November 2009
|
$
|
250,000
|
|
Fiscal 2010: July 2010
|
300,000
|
|
|
Fiscal 2011: July 2011
|
250,000
|
|
|
Fiscal 2012: February 2012
|
100,000
|
|
|
Fiscal 2015: October 2014
|
200,000
|
|
|
Fiscal 2017: January 2017
|
200,000
|
|
|
Fiscal 2018: July 2018
|
350,000
|
|
|
Fiscal 2019: July 2019
|
350,000
|
|
|
Total
|
$
|
2,000,000
|
|
Repurchase Activity
|
Total Shares Purchased
|
Average Price
Paid Per Share (1) |
Total Shares Purchased As Part Of Publicly Announced Programs
|
Remaining Authorized Repurchases (2)
|
||||
June 29, 2019 - July 26, 2019
|
—
|
|
$
|
—
|
|
—
|
|
$65.0 million
|
July 27, 2019 - August 23, 2019
|
668,830
|
|
59.45
|
|
668,830
|
|
$375.2 million
|
|
August 24, 2019 - September 27, 2019
|
233,357
|
|
61.33
|
|
233,357
|
|
$360.9 million
|
|
Total
|
902,187
|
|
|
902,187
|
|
|
(1)
|
Average price paid per share excludes commission costs.
|
(2)
|
Amounts represent the approximate dollar value of the maximum remaining number of shares that may yet be purchased under the stock repurchase program, and excludes commission costs.
|
|
Fiscal Year Ended
|
||||||||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted) (1)
|
September 29, 2017
(as adjusted) (1)
|
September 30, 2016 (1)
|
September 25, 2015 (1)
|
||||||||||
Operations:
|
|
|
|
|
|
||||||||||
Revenue
|
$
|
1,241,620
|
|
$
|
1,054,600
|
|
$
|
1,080,177
|
|
$
|
1,025,738
|
|
$
|
970,638
|
|
Gross margin
|
1,080,766
|
|
927,038
|
|
961,648
|
|
916,756
|
|
875,822
|
|
|||||
Operating expenses
|
823,689
|
|
743,533
|
|
714,515
|
|
684,961
|
|
662,594
|
|
|||||
Income before provision for income taxes
|
282,307
|
|
196,374
|
|
255,145
|
|
235,904
|
|
245,782
|
|
|||||
Net income attributable to Dolby Laboratories, Inc.
|
255,151
|
|
41,746
|
|
206,481
|
|
185,860
|
|
181,390
|
|
|||||
|
|
|
|
|
|
||||||||||
Net Income Per Share:
|
|
|
|
|
|
||||||||||
Basic
|
$
|
2.51
|
|
$
|
0.40
|
|
$
|
2.03
|
|
$
|
1.85
|
|
$
|
1.77
|
|
Diluted
|
$
|
2.44
|
|
$
|
0.39
|
|
$
|
2.00
|
|
$
|
1.81
|
|
$
|
1.75
|
|
Weighted-Average Shares Outstanding:
|
|
|
|
|
|
||||||||||
Basic
|
101,629
|
|
103,377
|
|
101,784
|
|
100,717
|
|
102,354
|
|
|||||
Diluted
|
104,572
|
|
106,978
|
|
103,286
|
|
102,424
|
|
103,862
|
|
|||||
|
|
|
|
|
|
||||||||||
Cash dividends declared per common share
|
$
|
0.79
|
|
$
|
0.67
|
|
$
|
0.58
|
|
$
|
0.50
|
|
$
|
0.42
|
|
Cash dividend paid per common share
|
$
|
0.76
|
|
$
|
0.64
|
|
$
|
0.56
|
|
$
|
0.48
|
|
$
|
0.40
|
|
|
Fiscal Year Ended
|
||||||||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted) (1)
|
September 29, 2017
(as adjusted) (1)
|
September 30, 2016 (1)
|
September 25, 2015 (1)
|
||||||||||
Cash and cash equivalents
|
$
|
797,210
|
|
$
|
918,063
|
|
$
|
627,017
|
|
$
|
516,112
|
|
$
|
531,926
|
|
Working capital
|
1,074,687
|
|
1,211,378
|
|
1,061,218
|
|
546,647
|
|
611,548
|
|
|||||
Short-term and long-term investments
|
298,733
|
|
365,920
|
|
562,121
|
|
515,533
|
|
459,916
|
|
|||||
Total assets
|
2,821,749
|
|
2,865,387
|
|
2,836,463
|
|
2,310,106
|
|
2,133,293
|
|
|||||
Total stockholders’ equity—Dolby Laboratories, Inc.
|
2,307,351
|
|
2,363,936
|
|
2,391,627
|
|
1,970,256
|
|
1,807,068
|
|
(1)
|
The selected financial data for the fiscal years ended September 28, 2018 and September 29, 2017 have been adjusted to reflect the adoption of ASU 2014-09, Revenue from Contracts with Customers, or "ASC 606". The selected financial data for fiscal years ended September 30, 2016 and September 25, 2015 presented in the table above reflects ASC 605, and has not been recast for, and does not reflect the adoption of ASC 606. For additional information, refer to Note 2 "Summary Of Significant Accounting Policies" to our consolidated financial statements.
|
|
Fiscal Year Ended
|
|
2019 vs. 2018
|
|
2018 vs. 2017
|
||||
Licensing
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|
$
|
%
|
|
$
|
%
|
Revenue
|
$1,107,280
|
$940,777
|
$965,864
|
|
$166,503
|
18%
|
|
$(25,087)
|
(3)%
|
Percentage of total revenue
|
89%
|
89%
|
89%
|
|
|
|
|
|
|
Cost of licensing
|
57,531
|
42,583
|
39,329
|
|
14,948
|
35%
|
|
3,254
|
8%
|
Gross margin
|
1,049,749
|
898,194
|
926,535
|
|
151,555
|
17%
|
|
(28,341)
|
(3)%
|
Gross margin percentage
|
95%
|
95%
|
96%
|
|
|
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
Mobile
|
á
|
Higher revenues from patent licensing and the adoption of our technologies into more devices, partially offset by lower recoveries
|
ßà
|
No significant fluctuations
|
Broadcast
|
á
|
Higher revenues from patent licensing, recoveries, and TVs, partially offset by lower volume of STBs
|
||
Other
|
á
|
Higher revenues from Dolby Cinema, gaming, and automotive recoveries, partially offset by lower licensing in Dolby Voice
|
||
CE
|
á
|
Higher volume of DMAs and higher patent licensing, partially offset by lower recoveries
|
||
PC
|
á
|
Higher revenues from recoveries and patent licensing, partially offset by lower ASP from decreasing number of PCs with optical disc functionality
|
Factor
|
Revenue
|
Gross Margin
|
||
PC
|
â
|
Lower ASP from decreasing number of PCs with optical disc functionality and lower recoveries, partially offset by higher patent licensing
|
ßà
|
No significant fluctuations
|
CE
|
á
|
Higher patent licensing and higher volume of DMAs, partially offset by lower volume of DVDs
|
||
Broadcast
|
â
|
Lower patent licensing, volume of STBs and TVs, and lower recoveries
|
||
Other
|
á
|
Higher patent licensing, revenue from Dolby Cinema, and Via administrative fees, partially offset by lower recoveries in automotive
|
||
Mobile
|
á
|
Higher recoveries and adoption of our technologies into more devices, partially offset by lower patent licensing
|
|
Fiscal Year Ended
|
|
2019 vs. 2018
|
|
2018 vs. 2017
|
||||
Products and Services
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|
$
|
%
|
|
$
|
%
|
Revenue
|
$134,340
|
$113,823
|
$114,313
|
|
$20,517
|
18%
|
|
$(490)
|
—%
|
Percentage of total revenue
|
11%
|
11%
|
11%
|
|
|
|
|
|
|
Cost of products and services
|
103,323
|
84,979
|
79,200
|
|
18,344
|
22%
|
|
5,779
|
7%
|
Gross margin
|
31,017
|
28,844
|
35,113
|
|
2,173
|
8%
|
|
(6,269)
|
(18)%
|
Gross margin percentage
|
23%
|
25%
|
31%
|
|
|
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
Products
|
á
|
Higher revenues from Dolby Cinema and Dolby Voice products, and higher units of cinema equipment
|
â
|
Higher excess & obsolete charges
|
Services
|
ßà
|
No significant fluctuations
|
á
|
Higher utilization of available capacity
|
Factor
|
Revenue
|
Gross Margin
|
||
Products
|
ßà
|
No significant fluctuations
|
â
|
Lower utilization of manufacturing capacity and higher excess & obsolete charges, partially offset by improved mix of products
|
Support & Other
|
â
|
Decreased support and maintenance services
|
â
|
Lower utilization of available capacity
|
|
Fiscal Year Ended
|
|
2019 vs. 2018
|
|
2018 vs. 2017
|
||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|
$
|
%
|
|
$
|
%
|
Research and development
|
$237,871
|
$236,794
|
$233,312
|
|
$1,077
|
—%
|
|
$3,482
|
1%
|
Percentage of total revenue
|
19%
|
22%
|
22%
|
|
|
|
|
|
|
Category
|
Key Drivers
|
|
Research & Development
|
ßà
|
No significant fluctuations
|
Category
|
Key Drivers
|
|
Facilities
|
á
|
Higher costs associated with our worldwide headquarters
|
Depreciation & Amortization
|
â
|
Lower depreciation as certain assets have been fully depreciated
|
Compensation & Benefits
|
á
|
Higher headcount on R&D projects along with merit increases across the employee base
|
|
Fiscal Year Ended
|
|
2019 vs. 2018
|
|
2018 vs. 2017
|
||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|
$
|
%
|
|
$
|
%
|
Sales and marketing
|
$343,835
|
$309,762
|
$296,661
|
|
$34,073
|
11%
|
|
$13,101
|
4%
|
Percentage of total revenue
|
28%
|
29%
|
27%
|
|
|
|
|
|
|
Category
|
Key Drivers
|
|
Legal, Professional, & Consulting
|
á
|
Increased IP related activities aimed at revenue generation
|
Marketing Programs
|
á
|
Higher costs related to marketing programs, including branding activities, and new product launches
|
Category
|
Key Drivers
|
|
Legal, Professional, & Consulting
|
á
|
Increased IP related activities aimed at revenue generation
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the employee base
|
Marketing Programs
|
á
|
Higher costs related to marketing efforts for growth initiatives
|
|
Fiscal Year Ended
|
|
2019 vs. 2018
|
|
2018 vs. 2017
|
||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|
$
|
%
|
|
$
|
%
|
General and administrative
|
$205,425
|
$197,423
|
$171,686
|
|
$8,002
|
4%
|
|
$25,737
|
15%
|
Percentage of total revenue
|
17%
|
19%
|
16%
|
|
|
|
|
|
|
Category
|
Key Drivers
|
|
Legal, Professional, & Consulting
|
á
|
Higher costs associated with various legal activities and patent filings
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base
|
Bad Debt
|
á
|
Higher charges recorded in the current period
|
Category
|
Key Drivers
|
|
Compensation & Benefits
|
á
|
Increase in headcount, merit increases, and higher employer costs
|
Legal, Professional, & Consulting
|
á
|
Higher costs associated with various legal activities, patent filings, and implementing regulatory changes
|
Stock-Based Compensation
|
á
|
Higher fair value of awards
|
|
Fiscal Year Ended
|
|
2019 vs. 2018
|
|
2018 vs. 2017
|
||||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|
$
|
%
|
|
$
|
%
|
||||||
Restructuring charges/(credits)
|
$36,558
|
$(446)
|
$12,856
|
|
$
|
37,004
|
|
(8,297
|
)%
|
|
$
|
(13,302
|
)
|
(103
|
)%
|
Percentage of total revenue
|
3%
|
—%
|
1%
|
|
|
|
|
|
|
|
Fiscal Year Ended
|
|
2019 vs. 2018
|
|
2018 vs. 2017
|
||||
Other Income/Expense
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|
$
|
%
|
|
$
|
%
|
Interest income
|
$24,919
|
$18,970
|
$9,577
|
|
$5,949
|
31%
|
|
$9,393
|
98%
|
Interest expense
|
(170)
|
(198)
|
(127)
|
|
28
|
(14)%
|
|
(71)
|
56%
|
Other income/(expense), net
|
481
|
(5,903)
|
(1,438)
|
|
6,384
|
(108)%
|
|
(4,465)
|
311%
|
Total
|
$25,230
|
$12,869
|
$8,012
|
|
$12,361
|
96%
|
|
$4,857
|
61%
|
Category
|
Key Drivers
|
|
Other Income/(Expense)
|
á
|
Decrease in other expense due to impairment charges recorded in the prior year on cost method equity investments that did not re-occur in 2019, higher valuation of current year equity method investment valuations, and lower foreign currency translation losses
|
Interest Income
|
á
|
Higher yields on investment balances
|
Category
|
Key Drivers
|
|
Interest Income
|
á
|
Higher yields on our increased investment balances
|
Other Income/(Expense)
|
â
|
Increase in other expense primarily due to impairment charges recorded on cost method equity investments
|
|
Fiscal Year Ended
|
||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
Provision for income taxes
|
$(26,802)
|
$(154,069)
|
$(48,039)
|
Effective tax rate
|
9%
|
78%
|
19%
|
Factor
|
Impact On Effective Tax Rate
|
|
Enactment of Tax Act
|
â
|
Lower tax expense due to a large tax charge for US tax reform in the prior year, a large tax benefit in the current year, and the reduction of the federal statutory rate
|
Factor
|
Impact On Effective Tax Rate
|
|
Enactment of Tax Act
|
á
|
Higher tax provision for deemed repatriation and write-down of deferred tax assets offset by higher benefit for the reduction of the federal statutory rate
|
Valuation Allowance
|
á
|
Higher tax provision reflecting valuation allowance for California R&D Tax Credits
|
Stock-Based Compensation
|
â
|
Higher benefit related to the settlement of stock-based awards
|
|
September 27,
2019 |
|
September 28,
2018 |
||||
Cash and cash equivalents
|
$
|
797,210
|
|
|
$
|
918,063
|
|
Short-term investments
|
119,146
|
|
|
178,138
|
|
||
Long-term investments
|
179,587
|
|
|
187,782
|
|
||
Accounts receivable, net
|
189,115
|
|
|
166,133
|
|
||
Accounts payable and accrued liabilities
|
283,356
|
|
|
265,050
|
|
||
Working capital
|
1,074,687
|
|
|
1,211,378
|
|
|
Fiscal Year Ended
|
|||||
|
September 27,
2019 |
September 28,
2018 |
||||
Net cash provided by operating activities
|
$
|
327,674
|
|
$
|
352,202
|
|
|
Fiscal Year Ended
|
|||||
|
September 27,
2019 |
September 28,
2018 |
||||
Net cash provided by (used in) investing activities
|
$
|
(56,229
|
)
|
$
|
78,086
|
|
Factor
|
Impact On Cash Flows
|
|
Purchase of Investments
|
á
|
Higher outflows for the purchase of marketable investment securities
|
Capital Expenditures
|
á
|
Higher expenditures for PP&E
|
Proceeds From Investments
|
â
|
Lower inflows from the sale & maturity of marketable investment securities
|
|
Fiscal Year Ended
|
|||||
|
September 27,
2019 |
September 28,
2018 |
||||
Net cash used in financing activities
|
$
|
(385,281
|
)
|
$
|
(133,629
|
)
|
Factor
|
Impact On Cash Flows
|
|
Share Repurchases
|
â
|
Higher outflows from increases in common stock repurchases
|
Common Stock Issuance
|
â
|
Lower inflows from employee stock option exercises
|
|
Payments Due By Fiscal Period
|
||||||||||||||
|
1 Year
|
2 - 3
Years |
4 - 5
Years |
More Than
5 Years |
Total
|
||||||||||
Naming rights
|
$
|
7,909
|
|
$
|
16,116
|
|
$
|
16,521
|
|
$
|
70,344
|
|
$
|
110,890
|
|
Operating leases
|
17,231
|
|
16,520
|
|
10,717
|
|
12,355
|
|
56,823
|
|
|||||
Purchase obligations
|
37,675
|
|
6,044
|
|
—
|
|
—
|
|
43,719
|
|
|||||
Donation commitments
|
4,243
|
|
282
|
|
282
|
|
1,059
|
|
5,866
|
|
|||||
Total
|
$
|
67,058
|
|
$
|
38,962
|
|
$
|
27,520
|
|
$
|
83,758
|
|
$
|
217,298
|
|
•
|
Australian Dollar
|
•
|
British Pound
|
•
|
Chinese Yuan
|
•
|
Euro
|
•
|
Polish Zloty
|
|
|
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
||||
ASSETS
|
|
|
||||
Current assets:
|
|
|
||||
Cash and cash equivalents
|
$
|
797,210
|
|
$
|
918,063
|
|
Restricted cash
|
8,383
|
|
7,187
|
|
||
Short-term investments
|
119,146
|
|
178,138
|
|
||
Accounts receivable, net of allowance for doubtful accounts of $9,775 and $5,258
|
189,115
|
|
166,133
|
|
||
Contract assets
|
195,651
|
|
165,959
|
|
||
Inventories, net
|
32,331
|
|
26,206
|
|
||
Prepaid expenses and other current assets
|
39,704
|
|
34,890
|
|
||
Total current assets
|
1,381,540
|
|
1,496,576
|
|
||
Long-term investments
|
179,587
|
|
187,782
|
|
||
Property, plant and equipment, net
|
537,432
|
|
514,182
|
|
||
Intangible assets, net
|
180,891
|
|
184,019
|
|
||
Goodwill
|
334,829
|
|
327,982
|
|
||
Deferred taxes
|
114,075
|
|
74,766
|
|
||
Other non-current assets
|
93,395
|
|
80,080
|
|
||
Total assets
|
$
|
2,821,749
|
|
$
|
2,865,387
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
||||
Current liabilities:
|
|
|
||||
Accounts payable
|
$
|
15,212
|
|
$
|
21,922
|
|
Accrued liabilities
|
268,144
|
|
243,128
|
|
||
Income taxes payable
|
3,506
|
|
2,680
|
|
||
Contract liabilities
|
19,991
|
|
17,468
|
|
||
Total current liabilities
|
306,853
|
|
285,198
|
|
||
Non-current contract liabilities
|
24,404
|
|
25,887
|
|
||
Other non-current liabilities
|
177,462
|
|
183,799
|
|
||
Total liabilities
|
508,719
|
|
494,884
|
|
||
|
|
|
||||
Stockholders’ equity:
|
|
|
||||
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 63,911,270 shares issued and outstanding at September 27, 2019 and 63,978,752 at September 28, 2018
|
58
|
|
61
|
|
||
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,229,820 shares issued and outstanding at September 27, 2019 and 39,261,035 at September 28, 2018
|
41
|
|
41
|
|
||
Additional paid-in capital
|
—
|
|
66,127
|
|
||
Retained earnings
|
2,327,877
|
|
2,313,539
|
|
||
Accumulated other comprehensive (loss)
|
(20,625
|
)
|
(15,832
|
)
|
||
Total stockholders’ equity – Dolby Laboratories, Inc.
|
2,307,351
|
|
2,363,936
|
|
||
Controlling interest
|
5,679
|
|
6,567
|
|
||
Total stockholders’ equity
|
2,313,030
|
|
2,370,503
|
|
||
Total liabilities and stockholders’ equity
|
$
|
2,821,749
|
|
$
|
2,865,387
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
||||||
Revenue:
|
|
|
|
||||||
Licensing
|
$
|
1,107,280
|
|
$
|
940,777
|
|
$
|
965,864
|
|
Products and services
|
134,340
|
|
113,823
|
|
114,313
|
|
|||
Total revenue
|
1,241,620
|
|
1,054,600
|
|
1,080,177
|
|
|||
|
|
|
|
||||||
Cost of revenue:
|
|
|
|
||||||
Cost of licensing
|
57,531
|
|
42,583
|
|
39,329
|
|
|||
Cost of products and services
|
103,323
|
|
84,979
|
|
79,200
|
|
|||
Total cost of revenue
|
160,854
|
|
127,562
|
|
118,529
|
|
|||
|
|
|
|
||||||
Gross margin
|
1,080,766
|
|
927,038
|
|
961,648
|
|
|||
|
|
|
|
||||||
Operating expenses:
|
|
|
|
||||||
Research and development
|
237,871
|
|
236,794
|
|
233,312
|
|
|||
Sales and marketing
|
343,835
|
|
309,762
|
|
296,661
|
|
|||
General and administrative
|
205,425
|
|
197,423
|
|
171,686
|
|
|||
Restructuring charges/(credits)
|
36,558
|
|
(446
|
)
|
12,856
|
|
|||
Total operating expenses
|
823,689
|
|
743,533
|
|
714,515
|
|
|||
|
|
|
|
||||||
Operating income
|
257,077
|
|
183,505
|
|
247,133
|
|
|||
|
|
|
|
||||||
Other income/expense:
|
|
|
|
||||||
Interest income
|
24,919
|
|
18,970
|
|
9,577
|
|
|||
Interest expense
|
(170
|
)
|
(198
|
)
|
(127
|
)
|
|||
Other income/(expense), net
|
481
|
|
(5,903
|
)
|
(1,438
|
)
|
|||
Total other income
|
25,230
|
|
12,869
|
|
8,012
|
|
|||
|
|
|
|
||||||
Income before income taxes
|
282,307
|
|
196,374
|
|
255,145
|
|
|||
Provision for income taxes
|
(26,802
|
)
|
(154,069
|
)
|
(48,039
|
)
|
|||
Net income including controlling interest
|
255,505
|
|
42,305
|
|
207,106
|
|
|||
Less: net (income) attributable to controlling interest
|
(354
|
)
|
(559
|
)
|
(625
|
)
|
|||
Net income attributable to Dolby Laboratories, Inc.
|
$
|
255,151
|
|
$
|
41,746
|
|
$
|
206,481
|
|
|
|
|
|
||||||
Net income per share:
|
|
|
|
||||||
Basic
|
$
|
2.51
|
|
$
|
0.40
|
|
$
|
2.03
|
|
Diluted
|
$
|
2.44
|
|
$
|
0.39
|
|
$
|
2.00
|
|
Weighted-average shares outstanding:
|
|
|
|
||||||
Basic
|
101,629
|
|
103,377
|
|
101,784
|
|
|||
Diluted
|
104,572
|
|
106,978
|
|
103,286
|
|
|||
|
|
|
|
||||||
Related party rent expense and restructuring charges:
|
|
|
|
||||||
Included in operating expenses
|
$
|
16,360
|
|
$
|
3,483
|
|
$
|
3,142
|
|
Included in net income attributable to controlling interest
|
$
|
572
|
|
$
|
712
|
|
$
|
702
|
|
|
|
|
|
||||||
Cash dividend declared per common share
|
$
|
0.79
|
|
$
|
0.67
|
|
$
|
0.58
|
|
Cash dividend paid per common share
|
$
|
0.76
|
|
$
|
0.64
|
|
$
|
0.56
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
||||||
Net income including controlling interest
|
$
|
255,505
|
|
$
|
42,305
|
|
$
|
207,106
|
|
Other comprehensive income:
|
|
|
|
||||||
Currency translation adjustments, net of tax of ($439), $106, and $(621)
|
(10,166
|
)
|
(5,578
|
)
|
3,653
|
|
|||
Unrealized gains/(losses) on investments, net of tax of $58, $89, and $38
|
5,146
|
|
(2,571
|
)
|
(1,119
|
)
|
|||
Total other comprehensive income/(loss), net of tax
|
(5,020
|
)
|
(8,149
|
)
|
2,534
|
|
|||
|
|
|
|
||||||
Total comprehensive income
|
250,485
|
|
34,156
|
|
209,640
|
|
|||
Less: comprehensive (income) attributable to controlling interest
|
(127
|
)
|
(489
|
)
|
(715
|
)
|
|||
Comprehensive income attributable to Dolby Laboratories, Inc.
|
$
|
250,358
|
|
$
|
33,667
|
|
$
|
208,925
|
|
|
Dolby Laboratories, Inc.
|
|
|
|||||||||||||||||||||||||
|
Class A
|
Class B
|
APIC
|
Retained
Earnings
|
AOCI
|
Total Stockholders’ Equity
|
Controlling
Interest
|
Total
|
||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
|
Amount
|
|||||||||||||||||||||||
Balance at September 30, 2016 (as adjusted) (1)
|
57,018
|
|
$
|
57
|
|
44,404
|
|
$
|
44
|
|
$
|
42,032
|
|
$
|
2,188,526
|
|
$
|
(10,197
|
)
|
$
|
2,220,462
|
|
$
|
8,479
|
|
$
|
2,228,941
|
|
Net income
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
206,481
|
|
|
|
206,481
|
|
625
|
|
207,106
|
|
||||||||
Other comprehensive income, net of tax
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2,444
|
|
2,444
|
|
90
|
|
2,534
|
|
||||||||
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(2,094
|
)
|
(2,094
|
)
|
||||||||
Stock-based compensation expense
|
—
|
|
—
|
|
—
|
|
—
|
|
65,343
|
|
—
|
|
—
|
|
65,343
|
|
—
|
|
65,343
|
|
||||||||
Repurchase of common stock
|
(2,025
|
)
|
(2
|
)
|
—
|
|
—
|
|
(99,998
|
)
|
—
|
|
—
|
|
(100,000
|
)
|
—
|
|
(100,000
|
)
|
||||||||
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(57,059
|
)
|
—
|
|
(57,059
|
)
|
—
|
|
(57,059
|
)
|
||||||||
Tax benefit from employee stock plans
|
—
|
|
—
|
|
—
|
|
—
|
|
1,634
|
|
—
|
|
—
|
|
1,634
|
|
—
|
|
1,634
|
|
||||||||
Common stock issued under employee stock plans
|
3,138
|
|
2
|
|
—
|
|
—
|
|
69,996
|
|
—
|
|
—
|
|
69,998
|
|
—
|
|
69,998
|
|
||||||||
Tax withholdings on vesting of restricted stock
|
(379
|
)
|
—
|
|
—
|
|
—
|
|
(17,676
|
)
|
—
|
|
—
|
|
(17,676
|
)
|
—
|
|
(17,676
|
)
|
||||||||
Common stock transfers - Class B to Class A
|
1,530
|
|
1
|
|
(1,530
|
)
|
(1
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Balance at September 29, 2017 (as adjusted)
|
59,282
|
|
58
|
|
42,874
|
|
43
|
|
61,331
|
|
2,337,948
|
|
(7,753
|
)
|
2,391,627
|
|
7,100
|
|
2,398,727
|
|
||||||||
Net income
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
41,746
|
|
—
|
|
41,746
|
|
559
|
|
42,305
|
|
||||||||
Other comprehensive income, net of tax
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(8,079
|
)
|
(8,079
|
)
|
(70
|
)
|
(8,149
|
)
|
||||||||
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(1,022
|
)
|
(1,022
|
)
|
||||||||
Stock-based compensation expense
|
—
|
|
—
|
|
—
|
|
—
|
|
71,249
|
|
—
|
|
—
|
|
71,249
|
|
—
|
|
71,249
|
|
||||||||
Repurchase of common stock
|
(2,381
|
)
|
(2
|
)
|
—
|
|
—
|
|
(150,468
|
)
|
—
|
|
—
|
|
(150,470
|
)
|
—
|
|
(150,470
|
)
|
||||||||
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(66,155
|
)
|
—
|
|
(66,155
|
)
|
—
|
|
(66,155
|
)
|
||||||||
Tax benefit from employee stock plans
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Common stock issued under employee stock plans
|
3,823
|
|
3
|
|
—
|
|
—
|
|
106,159
|
|
—
|
|
—
|
|
106,162
|
|
—
|
|
106,162
|
|
||||||||
Tax withholdings on vesting of restricted stock
|
(358
|
)
|
—
|
|
—
|
|
—
|
|
(22,144
|
)
|
—
|
|
—
|
|
(22,144
|
)
|
—
|
|
(22,144
|
)
|
||||||||
Common stock transfers - Class B to Class A
|
3,613
|
|
2
|
|
(3,613
|
)
|
(2
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Balance at September 28, 2018 (as adjusted)
|
63,979
|
|
61
|
|
39,261
|
|
41
|
|
66,127
|
|
2,313,539
|
|
(15,832
|
)
|
2,363,936
|
|
6,567
|
|
2,370,503
|
|
||||||||
Net income
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
255,151
|
|
—
|
|
255,151
|
|
354
|
|
255,505
|
|
||||||||
Other comprehensive income, net of tax
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(4,793
|
)
|
(4,793
|
)
|
(227
|
)
|
(5,020
|
)
|
||||||||
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(1,015
|
)
|
(1,015
|
)
|
||||||||
Stock-based compensation expense
|
—
|
|
—
|
|
—
|
|
—
|
|
76,580
|
|
—
|
|
—
|
|
76,580
|
|
—
|
|
76,580
|
|
||||||||
Repurchase of common stock
|
(5,268
|
)
|
(4
|
)
|
—
|
|
—
|
|
(177,264
|
)
|
(163,317
|
)
|
—
|
|
(340,585
|
)
|
—
|
|
(340,585
|
)
|
||||||||
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(77,496
|
)
|
—
|
|
(77,496
|
)
|
—
|
|
(77,496
|
)
|
||||||||
Tax benefit from employee stock plans
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Common stock issued under employee stock plans
|
2,514
|
|
1
|
|
—
|
|
—
|
|
57,345
|
|
—
|
|
—
|
|
57,346
|
|
—
|
|
57,346
|
|
||||||||
Tax withholdings on vesting of restricted stock
|
(345
|
)
|
—
|
|
—
|
|
—
|
|
(22,788
|
)
|
—
|
|
—
|
|
(22,788
|
)
|
—
|
|
(22,788
|
)
|
||||||||
Common stock transfers - Class B to Class A
|
3,031
|
|
—
|
|
(3,031
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Balance at September 27, 2019
|
63,911
|
|
$
|
58
|
|
36,230
|
|
$
|
41
|
|
$
|
—
|
|
$
|
2,327,877
|
|
$
|
(20,625
|
)
|
$
|
2,307,351
|
|
$
|
5,679
|
|
$
|
2,313,030
|
|
(1)
|
The cumulative effect of the adoption of ASU 2014-09, Revenue from Contracts with Customers ("ASC 606") resulted in an adjustment to retained earnings of $250.2 million as of September 30, 2016.
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
||||||
Operating activities:
|
|
|
|
||||||
Net income including controlling interest
|
$
|
255,505
|
|
$
|
42,305
|
|
$
|
207,106
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||||
Depreciation and amortization
|
85,123
|
|
81,283
|
|
84,308
|
|
|||
Stock-based compensation
|
76,580
|
|
71,249
|
|
65,343
|
|
|||
Amortization of premium on investments
|
358
|
|
2,473
|
|
2,758
|
|
|||
Provision for doubtful accounts
|
4,523
|
|
2,413
|
|
924
|
|
|||
Deferred income taxes
|
(40,191
|
)
|
61,059
|
|
(35,046
|
)
|
|||
Restructuring charge for exit of leased facility
|
33,251
|
|
—
|
|
—
|
|
|||
Other non-cash items affecting net income
|
6,952
|
|
7,570
|
|
2,886
|
|
|||
Changes in operating assets and liabilities:
|
|
|
|
||||||
Accounts receivable, net
|
(27,492
|
)
|
100,129
|
|
(56,559
|
)
|
|||
Contract assets
|
(29,708
|
)
|
(2,502
|
)
|
(5,519
|
)
|
|||
Inventories
|
(16,098
|
)
|
(6,602
|
)
|
(11,922
|
)
|
|||
Prepaid expenses and other assets
|
(6,200
|
)
|
(52,485
|
)
|
(12,302
|
)
|
|||
Accounts payable and accrued liabilities
|
169
|
|
(29,019
|
)
|
103,505
|
|
|||
Income taxes, net
|
(2,186
|
)
|
39,738
|
|
26,950
|
|
|||
Contract liabilities
|
1,084
|
|
(59
|
)
|
4,980
|
|
|||
Other non-current liabilities
|
(13,996
|
)
|
34,650
|
|
381
|
|
|||
Net cash provided by operating activities
|
327,674
|
|
352,202
|
|
377,793
|
|
|||
|
|
|
|
||||||
Investing activities:
|
|
|
|
||||||
Purchases of investment securities
|
(265,361
|
)
|
(174,195
|
)
|
(289,530
|
)
|
|||
Proceeds from sales of investment securities
|
200,636
|
|
123,058
|
|
84,047
|
|
|||
Proceeds from maturities of investment securities
|
136,951
|
|
237,432
|
|
152,324
|
|
|||
Purchases of property, plant, and equipment
|
(96,281
|
)
|
(72,814
|
)
|
(99,617
|
)
|
|||
Payments for business acquisitions, net of cash acquired
|
(14,919
|
)
|
(22,852
|
)
|
—
|
|
|||
Purchase of intangible assets
|
(17,255
|
)
|
(12,543
|
)
|
(5,250
|
)
|
|||
Net cash provided by/(used in) investing activities
|
(56,229
|
)
|
78,086
|
|
(158,026
|
)
|
|||
|
|
|
|
||||||
Financing activities:
|
|
|
|
||||||
Proceeds from issuance of common stock
|
57,346
|
|
106,162
|
|
69,998
|
|
|||
Repurchase of common stock
|
(340,585
|
)
|
(150,470
|
)
|
(100,000
|
)
|
|||
Payment of cash dividend
|
(77,496
|
)
|
(66,155
|
)
|
(57,059
|
)
|
|||
Distribution to controlling interest
|
(1,015
|
)
|
(1,022
|
)
|
(2,094
|
)
|
|||
Shares repurchased for tax withholdings on vesting of restricted stock
|
(22,788
|
)
|
(22,144
|
)
|
(17,676
|
)
|
|||
Payment of deferred consideration for prior business combination
|
(743
|
)
|
—
|
|
—
|
|
|||
Net cash used in financing activities
|
(385,281
|
)
|
(133,629
|
)
|
(106,831
|
)
|
|||
|
|
|
|
||||||
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash
|
(5,821
|
)
|
(5,777
|
)
|
1,675
|
|
|||
Net increase/(decrease) in cash, cash equivalents, and restricted cash
|
(119,657
|
)
|
290,882
|
|
114,611
|
|
|||
Cash, cash equivalents, and restricted cash at beginning of period
|
925,250
|
|
634,368
|
|
519,757
|
|
|||
Cash, cash equivalents, and restricted cash at end of period
|
$
|
805,593
|
|
$
|
925,250
|
|
$
|
634,368
|
|
|
|
|
|
||||||
Supplemental disclosure:
|
|
|
|
||||||
Cash paid for income taxes, net of refunds received
|
$
|
59,722
|
|
$
|
60,875
|
|
$
|
56,760
|
|
|
|
|
|
||||||
Non-cash investing and financing activities:
|
|
|
|
||||||
Property, plant, and equipment purchased and unpaid at period-end
|
$
|
(324
|
)
|
$
|
7,990
|
|
$
|
(9,613
|
)
|
Purchase consideration payable for acquisition
|
$
|
1,700
|
|
$
|
3,750
|
|
$
|
—
|
|
Purchase consideration payable for intangibles
|
$
|
1,881
|
|
$
|
200
|
|
$
|
—
|
|
•
|
Estimates of sales-based royalty revenue that has not been reported by our licensees at period end
|
•
|
Estimation of variable consideration from our customers
|
•
|
Estimated standalone selling prices of distinct performance obligations in an customer contract
|
•
|
Valuation allowances for accounts receivable
|
•
|
Carrying values of inventories and certain PP&E, goodwill, and intangible assets
|
•
|
Fair values of investments
|
•
|
Accrued liabilities, including liabilities for unrecognized tax benefits
|
•
|
Deferred income tax assets and liabilities
|
•
|
Stock-based compensation
|
PP&E Category
|
Useful Life
|
Computer equipment and software
|
3 to 5 years
|
Machinery and equipment
|
3 to 8 years
|
Furniture and fixtures
|
5 to 8 years
|
Leasehold improvements
|
Lesser of useful life or related lease term
|
Equipment provided under operating leases
|
15 years
|
Buildings and building improvements
|
20 to 40 years
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Advertising and promotional costs
|
$
|
49,118
|
|
$
|
49,519
|
|
$
|
47,402
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Foreign currency transaction (losses)
|
$
|
(260
|
)
|
$
|
(823
|
)
|
$
|
(74
|
)
|
•
|
We estimate and record per-unit royalty-based revenue earned from our licensees’ shipments in the same period in which those shipments occur, instead of recognizing our per-unit royalty-based revenue in the quarter in which it is reported to us by our licensees, which is generally in the quarter after those shipments have occurred. To the extent that our revenues are influenced by seasonal trends, the trends will impact revenue one fiscal quarter earlier than was previously the case;
|
•
|
We record a favorable or unfavorable adjustment based on the difference between estimated and actual sales when we receive reporting of sales–based royalties on royalty statements from the licensees, generally in the subsequent fiscal quarter;
|
•
|
For certain transactions that have extended payment and minimum commitment terms with no further performance obligations, we recognize licensing revenues on the later of contract execution or effective date regardless of when the amounts are due and payable;
|
•
|
We recorded a one-time adjustment of $174.4 million to the period ending September 29, 2018 retained earnings to reflect the full impact of the accounting upon adoption.
|
|
Fiscal Year-To-Date Ended
|
||||||||
|
September 28, 2018
(as previously reported)
|
Effect of Adopting ASC 606
|
September 28, 2018
(as adjusted)
|
||||||
Revenue
|
$
|
1,171,924
|
|
$
|
(117,324
|
)
|
$
|
1,054,600
|
|
Gross margin
|
1,043,664
|
|
(116,626
|
)
|
927,038
|
|
|||
Provision for income taxes
|
(190,062
|
)
|
35,993
|
|
(154,069
|
)
|
|||
Net income attributable to Dolby Laboratories, Inc.
|
122,246
|
|
(80,500
|
)
|
41,746
|
|
|||
Diluted earnings per share
|
$
|
1.14
|
|
$
|
(0.75
|
)
|
$
|
0.39
|
|
|
Fiscal Year-to-Date Ended
|
||||||||
|
September 28, 2018
(as previously reported)¹
|
Effect of Adopting ASC 606
|
September 28, 2018
(as adjusted)
|
||||||
Operating activities:
|
|
|
|
||||||
Net income including controlling interest
|
$
|
122,805
|
|
$
|
(80,500
|
)
|
$
|
42,305
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||||
Provision for doubtful accounts
|
2,507
|
|
(94
|
)
|
2,413
|
|
|||
Deferred income taxes
|
89,934
|
|
(28,875
|
)
|
61,059
|
|
|||
Changes in operating assets and liabilities:
|
|
|
|
||||||
Accounts receivable
|
(65,723
|
)
|
165,852
|
|
100,129
|
|
|||
Contract assets
|
—
|
|
(2,502
|
)
|
(2,502
|
)
|
|||
Prepaid expenses and other assets
|
(14,895
|
)
|
(37,590
|
)
|
(52,485
|
)
|
|||
Accounts payable and other liabilities
|
15,690
|
|
(44,709
|
)
|
(29,019
|
)
|
|||
Contract liabilities
|
4,362
|
|
(4,421
|
)
|
(59
|
)
|
|||
Other non-current liabilities
|
1,811
|
|
32,839
|
|
34,650
|
|
|||
Net cash provided by operating activities
|
352,202
|
|
—
|
|
352,202
|
|
•
|
used the transaction price at the date on which the contract was completed rather than estimating variable consideration amounts in the comparative reporting period;
|
•
|
did not disclose the amount of the transaction price allocated to the remaining performance obligations or provide an explanation of when we expect to recognize that amount as revenue for reporting periods presented before the date of initial adoption;
|
•
|
reflected the aggregate effect of contract modifications in accounting for the contracts open as of the earliest reporting period presented;
|
•
|
did not adjust transaction prices for the effects of a significant financing component, if at contract inception, we expected the period between customer payment and the transfer of goods or services to be one year or less.
|
A.
|
Identification of the Contract or Contracts with Customers
|
B.
|
Identification of Performance Obligations in a Contract
|
•
|
Licensing. We license our technologies, including patents, to a range of customers who incorporate them into their products for enhanced audio, imaging and voice functionality across broadcast, mobile, CE, PC, gaming, and other markets.
|
•
|
Product Sales. We design and provide audio and imaging products for the cinema, television, broadcast, communications, and entertainment industries.
|
•
|
Services. We provide various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training, mixing room alignment, equalization, as well as audio, color and light image calibration.
|
•
|
PCS. We provide PCS for products sold and for the equipment leased, and we support the implementation of our licensing technologies in our licensees’ products.
|
•
|
Equipment Leases. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences by leasing equipment and licensing our intellectual property.
|
•
|
Licensing Administration Fees. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via Licensing Corporation.
|
•
|
Digital cinema server hardware and embedded software, which is highly dependent on and highly interrelated with the hardware. Accordingly, the hardware and embedded software represent a single performance obligation.
|
•
|
The right to support and maintenance, which is included with the purchase of the digital cinema server hardware, is a distinct performance obligation.
|
•
|
The right to receive commissioning services is a distinct performance obligation within the sale of the Dolby Atmos Cinema Processor. These services consist of the review of venue designs specifying proposed speaker placement as well as calibration services performed for installed speakers to ensure optimal playback.
|
C.
|
Determination of Transaction Price for Performance Obligations in a Contract
|
D.
|
Allocation of Transaction Price to Distinct Performance Obligations in a Contract
|
E.
|
Revenue Recognition as Control is Transferred to a Customer
|
F.
|
Disaggregation of revenue
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
September 27, 2019
|
|
September 28, 2018
|
||||||||
Revenue
|
|
|
|
(as adjusted)
|
|||||||
Licensing
|
$
|
1,107,280
|
|
89
|
%
|
|
$
|
940,777
|
|
89
|
%
|
Products and services
|
134,340
|
|
11
|
%
|
|
113,823
|
|
11
|
%
|
||
Total revenue
|
$
|
1,241,620
|
|
100
|
%
|
|
$
|
1,054,600
|
|
100
|
%
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
September 27, 2019
|
|
September 28, 2018
|
||||||||
Revenue By Market
|
|
|
|
(as adjusted)
|
|||||||
Broadcast
|
$
|
474,147
|
|
43
|
%
|
|
$
|
385,705
|
|
41
|
%
|
Mobile
|
193,052
|
|
17
|
%
|
|
148,356
|
|
16
|
%
|
||
CE
|
154,399
|
|
14
|
%
|
|
144,132
|
|
15
|
%
|
||
PC
|
113,597
|
|
10
|
%
|
|
106,765
|
|
11
|
%
|
||
Other
|
172,085
|
|
16
|
%
|
|
155,819
|
|
17
|
%
|
||
Total licensing revenue
|
$
|
1,107,280
|
|
100
|
%
|
|
$
|
940,777
|
|
100
|
%
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
September 27, 2019
|
|
September 28, 2018
|
||||||||
Revenue By Geographic Location
|
|
|
|
(as adjusted)
|
|||||||
United States
|
$
|
449,203
|
|
36
|
%
|
|
$
|
353,235
|
|
33
|
%
|
International
|
792,417
|
|
64
|
%
|
|
701,365
|
|
67
|
%
|
||
Total revenue
|
$
|
1,241,620
|
|
100
|
%
|
|
$
|
1,054,600
|
|
100
|
%
|
G.
|
Contract balances
|
|
September 27, 2019
|
September 28, 2018
|
Change ($)
|
Change (%)
|
|||||||
|
|
(as adjusted)
|
|
|
|||||||
Accounts receivable, net
|
$
|
189,115
|
|
$
|
166,133
|
|
$
|
22,982
|
|
14
|
%
|
Contract assets
|
195,651
|
|
165,959
|
|
29,692
|
|
18
|
%
|
|||
Other non-current assets
|
93,395
|
|
80,080
|
|
13,315
|
|
17
|
%
|
|||
Contract liabilities - current
|
19,991
|
|
17,468
|
|
2,523
|
|
14
|
%
|
|||
Contract liabilities - non-current
|
24,404
|
|
25,887
|
|
(1,483
|
)
|
(6
|
)%
|
|||
Other non-current liabilities
|
177,462
|
|
183,799
|
|
(6,337
|
)
|
(3
|
)%
|
Accounts Receivable, Net
|
September 27,
2019 |
|
September 28, 2018
(as adjusted)
|
||||
Trade accounts receivable
|
$
|
151,996
|
|
|
$
|
108,929
|
|
Accounts receivable from patent administration program licensees
|
46,894
|
|
|
62,462
|
|
||
Accounts receivable, gross
|
198,890
|
|
|
171,391
|
|
||
Less: allowance for doubtful accounts
|
(9,775
|
)
|
|
(5,258
|
)
|
||
Total
|
$
|
189,115
|
|
|
$
|
166,133
|
|
Allowance for Doubtful Accounts
|
Beginning Balance
|
Charged to
G&A
|
Deductions
|
Ending Balance
|
||||||||
For fiscal year ended:
|
|
|
|
|
||||||||
September 29, 2017
|
$
|
2,370
|
|
$
|
924
|
|
$
|
(327
|
)
|
$
|
2,967
|
|
September 28, 2018 (as adjusted)
|
2,967
|
|
2,413
|
|
(122
|
)
|
5,258
|
|
||||
September 27, 2019
|
5,258
|
|
4,523
|
|
(6
|
)
|
9,775
|
|
Inventories
|
September 27,
2019 |
|
September 28,
2018 |
||||
Raw materials
|
$
|
8,031
|
|
|
$
|
6,095
|
|
Work in process
|
4,872
|
|
|
4,044
|
|
||
Finished goods
|
19,428
|
|
|
16,067
|
|
||
Total
|
$
|
32,331
|
|
|
$
|
26,206
|
|
Prepaid Expenses And Other Current Assets
|
September 27,
2019 |
|
September 28, 2018
(as adjusted)
|
||||
Prepaid expenses
|
$
|
17,997
|
|
|
$
|
18,508
|
|
Other current assets
|
20,924
|
|
|
13,946
|
|
||
Income tax receivable
|
783
|
|
|
2,436
|
|
||
Total
|
$
|
39,704
|
|
|
$
|
34,890
|
|
Accrued Liabilities
|
September 27,
2019 |
|
September 28, 2018
(as adjusted)
|
||||
Accrued royalties
|
$
|
2,957
|
|
|
$
|
2,648
|
|
Amounts payable to patent administration program partners
|
58,899
|
|
|
69,061
|
|
||
Accrued compensation and benefits
|
78,716
|
|
|
84,491
|
|
||
Accrued professional fees
|
19,216
|
|
|
9,749
|
|
||
Unpaid PP&E additions
|
15,332
|
|
|
13,956
|
|
||
Other accrued liabilities
|
93,024
|
|
|
63,223
|
|
||
Total
|
$
|
268,144
|
|
|
$
|
243,128
|
|
Other Non-Current Liabilities
|
September 27,
2019 |
|
September 28, 2018
(as adjusted)
|
||||
Supplemental retirement plan obligations
|
$
|
3,466
|
|
|
$
|
3,388
|
|
Non-current tax liabilities (1)
|
136,323
|
|
|
129,253
|
|
||
Other liabilities
|
37,673
|
|
|
51,158
|
|
||
Total
|
$
|
177,462
|
|
|
$
|
183,799
|
|
(1)
|
Other long-term investments as of September 27, 2019 includes an investment that is not carried at fair value including an equity method investment of $1.7 million.
|
(1)
|
Other long-term investments as of September 28, 2018 include a marketable equity security of $0.2 million, and other investments that are not carried at fair value including an equity method investment of $0.4 million. During fiscal 2018, we recorded write-off charges to reduce the carrying value of two cost method equity investments to zero in recognition of an other-than-temporary impairment for each investment.
|
Asset Type
|
Primary Source
|
Update Frequency
|
Fair Value Methodology
|
Secondary Source
|
|
|
|
|
|
Level 1
|
|
|
|
|
Money Market Funds
|
ICE (Intercontinental Exchange)
|
Daily
|
$1 per share
|
Not Applicable
|
U.S. Government Bonds
|
ICE (Intercontinental Exchange)
|
Daily
|
Institutional Bond Quotes - evaluations based on various market and industry inputs
|
Bloomberg
|
|
|
|
|
|
Level 2
|
|
|
|
|
Certificates of Deposit
|
ICE (Intercontinental Exchange)
|
Monthly
|
Market Prices
|
Bloomberg
|
Commercial Paper
|
U.S. Bank Pricing Unit
|
Daily
|
Matrix Pricing
|
Not Applicable
|
Corporate Bonds
|
ICE (Intercontinental Exchange)
|
Daily
|
Institutional Bond Quotes - evaluations based on various market and industry inputs
|
Bloomberg
|
Municipal Debt Securities
|
ICE (Intercontinental Exchange)
|
Daily
|
Evaluations based on various market and industry inputs
|
Bloomberg
|
U.S. Agency Securities
|
ICE (Intercontinental Exchange)
|
Daily
|
Institutional Bond Quotes - evaluations based on various market and industry inputs
|
Bloomberg
|
Int'l Government Bonds
|
ICE (Intercontinental Exchange)
Extel Financial Ltd |
Daily
|
Evaluations based on various market factors
|
Bloomberg
|
|
September 27, 2019
|
|
September 28, 2018
|
||||||||||||||||||||||
|
Less Than 12 Months
|
Greater Than 12 Months
|
|
Less Than 12 Months
|
Greater Than 12 Months
|
||||||||||||||||||||
Investment Type
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
||||||||||||||||
Certificate of deposit
|
$
|
300
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
U.S. agency securities
|
—
|
|
—
|
|
4,787
|
|
(9
|
)
|
|
—
|
|
—
|
|
21,486
|
|
(302
|
)
|
||||||||
Government bonds
|
1,426
|
|
—
|
|
—
|
|
—
|
|
|
16,633
|
|
(332
|
)
|
—
|
|
—
|
|
||||||||
Commercial paper
|
—
|
|
—
|
|
—
|
|
—
|
|
|
5,737
|
|
(1
|
)
|
—
|
|
—
|
|
||||||||
Corporate bonds
|
7,647
|
|
(3
|
)
|
27,078
|
|
(32
|
)
|
|
143,051
|
|
(1,680
|
)
|
52,162
|
|
(624
|
)
|
||||||||
Municipal debt securities
|
9,552
|
|
(13
|
)
|
900
|
|
—
|
|
|
41,058
|
|
(191
|
)
|
6,965
|
|
(41
|
)
|
||||||||
Total
|
$
|
18,925
|
|
$
|
(16
|
)
|
$
|
32,765
|
|
$
|
(41
|
)
|
|
$
|
206,479
|
|
$
|
(2,204
|
)
|
$
|
80,613
|
|
$
|
(967
|
)
|
|
September 27, 2019
|
|
September 28, 2018
|
||||||||||
Range of maturity
|
Amortized Cost
|
Fair Value
|
|
Amortized Cost
|
Fair Value
|
||||||||
Due within 1 year
|
$
|
238,186
|
|
$
|
238,354
|
|
|
$
|
191,241
|
|
$
|
190,541
|
|
Due in 1 to 2 years
|
93,948
|
|
94,899
|
|
|
122,131
|
|
120,545
|
|
||||
Due in 2 to 3 years
|
81,793
|
|
82,957
|
|
|
67,423
|
|
66,637
|
|
||||
Total
|
$
|
413,927
|
|
$
|
416,210
|
|
|
$
|
380,795
|
|
$
|
377,723
|
|
Property, Plant, & Equipment
|
September 27,
2019 |
|
September 28,
2018 |
||||
Land
|
$
|
41,918
|
|
|
$
|
43,342
|
|
Buildings and building improvements
|
282,924
|
|
|
283,474
|
|
||
Leasehold improvements
|
66,730
|
|
|
66,866
|
|
||
Machinery and equipment
|
128,525
|
|
|
111,603
|
|
||
Computer equipment and software
|
219,455
|
|
|
194,079
|
|
||
Furniture and fixtures
|
34,191
|
|
|
30,556
|
|
||
Equipment provided under operating leases
|
161,372
|
|
|
139,201
|
|
||
Construction-in-progress
|
19,616
|
|
|
7,342
|
|
||
Property, plant, and equipment, gross
|
954,731
|
|
|
876,463
|
|
||
Less: accumulated depreciation
|
(417,299
|
)
|
|
(362,281
|
)
|
||
Property, plant, & equipment, net
|
$
|
537,432
|
|
|
$
|
514,182
|
|
|
Goodwill
|
||
Balance at September 29, 2017
|
$
|
311,087
|
|
Acquired goodwill
|
18,394
|
|
|
Translation adjustments
|
(1,499
|
)
|
|
Balance at September 28, 2018
|
$
|
327,982
|
|
Acquired goodwill
|
9,367
|
|
|
Translation adjustments
|
(2,520
|
)
|
|
Balance at September 27, 2019
|
$
|
334,829
|
|
|
September 27, 2019
|
|
September 28, 2018
|
||||||||||||||||
Intangible Assets, Net
|
Cost
|
Accumulated
Amortization
|
Net
|
|
Cost
|
Accumulated
Amortization
|
Net
|
||||||||||||
Acquired patents and technology
|
$
|
338,075
|
|
$
|
(176,867
|
)
|
$
|
161,208
|
|
|
$
|
319,082
|
|
$
|
(152,775
|
)
|
$
|
166,307
|
|
Customer relationships
|
64,728
|
|
(45,510
|
)
|
19,218
|
|
|
58,342
|
|
(41,012
|
)
|
17,330
|
|
||||||
Other intangibles
|
22,902
|
|
(22,437
|
)
|
465
|
|
|
22,742
|
|
(22,360
|
)
|
382
|
|
||||||
Total
|
$
|
425,705
|
|
$
|
(244,814
|
)
|
$
|
180,891
|
|
|
$
|
400,166
|
|
$
|
(216,147
|
)
|
$
|
184,019
|
|
Fiscal Year
|
Amortization Expense
|
||
2020
|
$
|
31,064
|
|
2021
|
30,825
|
|
|
2022
|
28,582
|
|
|
2023
|
23,646
|
|
|
2024
|
21,725
|
|
|
Thereafter
|
45,049
|
|
|
Total
|
$
|
180,891
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
Weighted-Average
Remaining
Contractual Life
|
Aggregate
Intrinsic
Value (1)
|
|||||
|
(in thousands)
|
|
(in years)
|
(in thousands)
|
|||||
Options outstanding at September 28, 2018
|
7,365
|
|
$
|
43.51
|
|
|
|
||
Grants
|
1,253
|
|
64.61
|
|
|
|
|||
Exercises
|
(1,177
|
)
|
36.17
|
|
|
|
|||
Forfeitures and cancellations
|
(240
|
)
|
54.24
|
|
|
|
|||
Options outstanding at September 27, 2019
|
7,201
|
|
48.03
|
|
6.3
|
$
|
114,500
|
|
|
|
|
|
|
|
|||||
Options vested and expected to vest at September 27, 2019
|
6,921
|
|
47.43
|
|
6.2
|
114,091
|
|
||
|
|
|
|
|
|||||
Options exercisable at September 27, 2019
|
4,355
|
|
$
|
41.18
|
|
5.4
|
98,496
|
|
(1)
|
Aggregate intrinsic value is based on the closing price of our Class A common stock on September 27, 2019 of $63.79 and excludes the impact of options that were not in-the-money.
|
|
Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||
|
(in thousands)
|
|
|||
Non-vested at September 28, 2018
|
2,806
|
|
$
|
51.62
|
|
Granted
|
1,348
|
|
64.97
|
|
|
Vested
|
(1,062
|
)
|
48.08
|
|
|
Forfeitures
|
(287
|
)
|
56.83
|
|
|
Non-vested at September 27, 2019
|
2,805
|
|
$
|
58.84
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Restricted stock units - vest date fair value
|
$
|
69,956
|
|
$
|
64,755
|
|
$
|
51,985
|
|
|
Fiscal Year Ended
|
|||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
|||
Expected term (in years)
|
4.90
|
|
5.06
|
|
5.13
|
|
Risk-free interest rate
|
2.7
|
%
|
2.2
|
%
|
2.1
|
%
|
Expected stock price volatility
|
22.9
|
%
|
22.6
|
%
|
27.4
|
%
|
Dividend yield
|
1.1
|
%
|
1.1
|
%
|
1.1
|
%
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Stock options granted - weighted-average grant date fair value
|
$
|
14.16
|
|
$
|
13.19
|
|
$
|
11.39
|
|
Stock options exercised - intrinsic value
|
33,226
|
|
63,973
|
|
28,544
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Stock options
|
$
|
17,742
|
|
$
|
21,083
|
|
$
|
18,630
|
|
Restricted stock units
|
54,650
|
|
46,162
|
|
43,171
|
|
|||
Employee stock purchase plan
|
4,188
|
|
4,004
|
|
3,542
|
|
|||
Total stock-based compensation
|
76,580
|
|
71,249
|
|
65,343
|
|
|||
Estimated benefit from income taxes
|
(12,884
|
)
|
(12,595
|
)
|
(18,959
|
)
|
|||
Total stock-based compensation, net of tax
|
$
|
63,696
|
|
$
|
58,654
|
|
$
|
46,384
|
|
|
Fiscal Year Ended
|
||||||||
Compensation Expense - By Classification
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Cost of products and services
|
$
|
1,710
|
|
$
|
1,574
|
|
$
|
1,458
|
|
Research and development
|
23,191
|
|
19,515
|
|
18,497
|
|
|||
Sales and marketing
|
28,137
|
|
24,997
|
|
26,175
|
|
|||
General and administrative
|
23,542
|
|
25,163
|
|
19,213
|
|
|||
Total stock-based compensation
|
76,580
|
|
71,249
|
|
65,343
|
|
|||
Estimated benefit from income taxes
|
(12,884
|
)
|
(12,595
|
)
|
(18,959
|
)
|
|||
Total stock-based compensation, net of tax
|
$
|
63,696
|
|
$
|
58,654
|
|
$
|
46,384
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Tax benefit - shares issued under ESPP
|
$
|
353
|
|
$
|
577
|
|
$
|
802
|
|
Authorization Period
|
Authorization Amount
|
||
Fiscal 2010: November 2009
|
$
|
250,000
|
|
Fiscal 2010: July 2010
|
300,000
|
|
|
Fiscal 2011: July 2011
|
250,000
|
|
|
Fiscal 2012: February 2012
|
100,000
|
|
|
Fiscal 2015: October 2014
|
200,000
|
|
|
Fiscal 2017: January 2017
|
200,000
|
|
|
Fiscal 2018: July 2018
|
350,000
|
|
|
Fiscal 2019: July 2019
|
350,000
|
|
|
Total
|
$
|
2,000,000
|
|
Quarterly Repurchase Activity
|
Shares
Repurchased
|
Cost (1)
|
Average Price Paid Per Share (2)
|
|||||
|
|
(in thousands)
|
|
|||||
Q1 - Quarter ended December 28, 2018
|
1,642,107
|
|
$
|
112,570
|
|
$
|
68.54
|
|
Q2 - Quarter ended March 29, 2019
|
1,318,250
|
|
85,351
|
|
64.73
|
|
||
Q3 - Quarter ended June 28, 2019
|
1,405,065
|
|
88,653
|
|
63.08
|
|
||
Q4 - Quarter ended September 27, 2019
|
902,187
|
|
54,011
|
|
59.94
|
|
||
Total
|
5,267,609
|
|
$
|
340,585
|
|
|
(1)
|
Cost of share repurchases includes the price paid per share and applicable commissions.
|
(2)
|
Average price paid per share excludes commission costs.
|
Fiscal Period
|
Announcement Date
|
Record Date
|
Payment Date
|
Cash Dividend Per Common Share
|
Dividend Payment
|
|||
Fiscal 2019
|
|
|
|
|
|
|
||
Q1 - Quarter ended December 28, 2018
|
January 30, 2019
|
February 12, 2019
|
February 21, 2019
|
$
|
0.19
|
|
$19.5 million
|
|
Q2 - Quarter ended March 29, 2019
|
May 1, 2019
|
May 14, 2019
|
May 22, 2019
|
$
|
0.19
|
|
$19.3 million
|
|
Q3 - Quarter ended June 28, 2019
|
August 1, 2019
|
August 12, 2019
|
August 20, 2019
|
$
|
0.19
|
|
$19.2 million
|
|
Q4 - Quarter ended September 27, 2019
|
November 14, 2019
|
November 26, 2019
|
December 4, 2019
|
$
|
0.22
|
|
$22.0 million
|
(1)
|
(1)
|
The dividend payment amount is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.
|
|
Fiscal Year Ended
|
|
Fiscal Year Ended
|
||||||||||||||||||||||
|
September 27, 2019
|
|
September 28, 2018
|
||||||||||||||||||||||
|
Investment Securities
|
Cash Flow Hedges
|
Currency Translation Adjustments
|
Total
|
|
Investment Securities
|
Cash Flow Hedges
|
Currency Translation Adjustments
|
Total
|
||||||||||||||||
Beginning Balance
|
$
|
(2,948
|
)
|
$
|
—
|
|
$
|
(12,884
|
)
|
$
|
(15,832
|
)
|
|
$
|
(377
|
)
|
$
|
—
|
|
$
|
(7,376
|
)
|
$
|
(7,753
|
)
|
Other comprehensive income before reclassifications:
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Unrealized gains/(losses)
|
5,131
|
|
(176
|
)
|
—
|
|
4,955
|
|
|
(2,213
|
)
|
—
|
|
—
|
|
(2,213
|
)
|
||||||||
Foreign currency translation gains/(losses) (1)
|
—
|
|
—
|
|
(9,500
|
)
|
(9,500
|
)
|
|
—
|
|
—
|
|
(5,614
|
)
|
(5,614
|
)
|
||||||||
Income tax effect - benefit/(expense)
|
37
|
|
—
|
|
(439
|
)
|
(402
|
)
|
|
—
|
|
—
|
|
106
|
|
106
|
|
||||||||
Net of tax
|
5,168
|
|
(176
|
)
|
(9,939
|
)
|
(4,947
|
)
|
|
(2,213
|
)
|
—
|
|
(5,508
|
)
|
(7,721
|
)
|
||||||||
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Realized gains/(losses) (1)
|
(43
|
)
|
176
|
|
—
|
|
133
|
|
|
(447
|
)
|
—
|
|
—
|
|
(447
|
)
|
||||||||
Income tax effect - benefit/(expense) (2)
|
21
|
|
—
|
|
—
|
|
21
|
|
|
89
|
|
—
|
|
—
|
|
89
|
|
||||||||
Net of tax
|
(22
|
)
|
176
|
|
—
|
|
154
|
|
|
(358
|
)
|
—
|
|
—
|
|
(358
|
)
|
||||||||
Net current-period other comprehensive income/(loss)
|
5,146
|
|
—
|
|
(9,939
|
)
|
(4,793
|
)
|
|
(2,571
|
)
|
—
|
|
(5,508
|
)
|
(8,079
|
)
|
||||||||
Ending Balance
|
$
|
2,198
|
|
$
|
—
|
|
$
|
(22,823
|
)
|
$
|
(20,625
|
)
|
|
$
|
(2,948
|
)
|
$
|
—
|
|
$
|
(12,884
|
)
|
$
|
(15,832
|
)
|
(1)
|
Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/expense, net in our consolidated statements of operations.
|
(2)
|
The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
||||||
Numerator:
|
|
|
|
||||||
Net income attributable to Dolby Laboratories, Inc.
|
$
|
255,151
|
|
$
|
41,746
|
|
$
|
206,481
|
|
|
|
|
|
||||||
Denominator:
|
|
|
|
||||||
Weighted-average shares outstanding—basic
|
101,629
|
|
103,377
|
|
101,784
|
|
|||
Potential common shares from options to purchase common stock
|
1,922
|
|
2,370
|
|
1,098
|
|
|||
Potential common shares from restricted stock units
|
1,021
|
|
1,231
|
|
404
|
|
|||
Weighted-average shares outstanding—diluted
|
104,572
|
|
106,978
|
|
103,286
|
|
|||
|
|
|
|
||||||
Net income per share attributable to Dolby Laboratories, Inc.:
|
|
|
|
||||||
Basic
|
$
|
2.51
|
|
$
|
0.40
|
|
$
|
2.03
|
|
Diluted
|
$
|
2.44
|
|
$
|
0.39
|
|
$
|
2.00
|
|
|
|
|
|
||||||
Antidilutive awards excluded from calculation:
|
|
|
|
||||||
Stock options
|
2,340
|
|
1,043
|
|
160
|
|
|||
Restricted stock units
|
1
|
|
6
|
|
—
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
||||||
United States
|
$
|
60,500
|
|
$
|
27,819
|
|
$
|
3,996
|
|
Foreign
|
221,807
|
|
168,555
|
|
251,149
|
|
|||
Total
|
$
|
282,307
|
|
$
|
196,374
|
|
$
|
255,145
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
||||||
Current:
|
|
|
|
||||||
Federal
|
$
|
14,144
|
|
$
|
40,624
|
|
$
|
30,718
|
|
State
|
394
|
|
333
|
|
610
|
|
|||
Foreign
|
64,335
|
|
59,383
|
|
55,531
|
|
|||
Total current
|
78,873
|
|
100,340
|
|
86,859
|
|
|||
|
|
|
|
||||||
Deferred:
|
|
|
|
||||||
Federal
|
(55,793
|
)
|
43,377
|
|
(35,824
|
)
|
|||
State
|
1,007
|
|
17,484
|
|
(4,604
|
)
|
|||
Foreign
|
2,715
|
|
(7,132
|
)
|
1,608
|
|
|||
Total deferred
|
(52,071
|
)
|
53,729
|
|
(38,820
|
)
|
|||
Provision for income taxes
|
$
|
26,802
|
|
$
|
154,069
|
|
$
|
48,039
|
|
|
Fiscal Year Ended
|
|||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
||||
Deferred income tax assets:
|
|
|
||||
Investments
|
$
|
2,099
|
|
$
|
2,215
|
|
Inventories
|
4,041
|
|
4,070
|
|
||
Net operating loss
|
2,050
|
|
2,174
|
|
||
Accrued expenses
|
13,917
|
|
12,573
|
|
||
Stock-based compensation
|
17,189
|
|
15,601
|
|
||
Revenue recognition
|
4,410
|
|
7,161
|
|
||
Depreciation and amortization
|
19,988
|
|
16,078
|
|
||
Research and development credits
|
28,777
|
|
21,302
|
|
||
Foreign tax credits
|
10,777
|
|
9,345
|
|
||
Deemed repatriated earnings tax benefit
|
33,357
|
|
—
|
|
||
Other
|
4,705
|
|
3,334
|
|
||
Total gross deferred income tax assets
|
141,310
|
|
93,853
|
|
||
Less: valuation allowance
|
(24,884
|
)
|
(16,256
|
)
|
||
Total deferred income tax assets
|
116,426
|
|
77,597
|
|
||
|
|
|
||||
Deferred income tax liabilities:
|
|
|
||||
Intangibles
|
(2,351
|
)
|
(2,831
|
)
|
||
Deferred income tax assets, net (non-current)
|
$
|
114,075
|
|
$
|
74,766
|
|
|
Fiscal Year Ended
|
|||||
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
|||
Federal statutory rate
|
21.0
|
%
|
24.6
|
%
|
35.0
|
%
|
State income taxes, net of federal effect
|
0.2
|
|
0.7
|
|
0.7
|
|
Stock-based compensation expense rate
|
(2.8
|
)
|
(5.2
|
)
|
1.4
|
|
Research and development tax credits
|
(3.0
|
)
|
(4.5
|
)
|
(3.7
|
)
|
Tax exempt interest
|
—
|
|
(0.1
|
)
|
(0.1
|
)
|
U.S. manufacturing tax incentives
|
—
|
|
(0.2
|
)
|
(0.8
|
)
|
Foreign rate differential
|
(2.6
|
)
|
(5.2
|
)
|
(22.9
|
)
|
Audit settlements
|
—
|
|
—
|
|
(0.6
|
)
|
Tax Act
|
(7.7
|
)
|
53.3
|
|
—
|
|
Change in Valuation Allowance
|
1.5
|
|
8.3
|
|
—
|
|
Other
|
2.9
|
|
6.8
|
|
9.8
|
|
Effective tax rate
|
9.5
|
%
|
78.5
|
%
|
18.8
|
%
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Beginning Balance
|
$
|
102,009
|
|
$
|
98,665
|
|
$
|
75,168
|
|
Gross increases - tax positions taken during prior years
|
115
|
|
—
|
|
308
|
|
|||
Gross decreases - tax positions taken during prior years
|
—
|
|
(2,209
|
)
|
—
|
|
|||
Gross increases - tax positions taken during current year
|
6,822
|
|
9,580
|
|
26,724
|
|
|||
Gross decreases - settlements with tax authorities during current year
|
—
|
|
(130
|
)
|
(1,101
|
)
|
|||
Lapse of statute of limitations
|
(407
|
)
|
(3,897
|
)
|
(2,434
|
)
|
|||
Ending Balance
|
$
|
108,539
|
|
$
|
102,009
|
|
$
|
98,665
|
|
|
Fiscal Year Ended
|
|||||
|
September 27,
2019 |
September 28,
2018 |
||||
Accrued interest
|
$
|
10,315
|
|
$
|
6,778
|
|
Accrued penalties
|
44
|
|
42
|
|
||
Total
|
$
|
10,359
|
|
$
|
6,820
|
|
|
Severance
|
Leased facility exit costs
|
Fixed assets write-off
|
Other associated costs
|
Total
|
||||||||||
Balance at September 28, 2018
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
124
|
|
$
|
124
|
|
Restructuring charges/(credits)
|
3,134
|
|
18,261
|
|
15,216
|
|
(53
|
)
|
36,558
|
|
|||||
Cash payments
|
(3,006
|
)
|
(4,577
|
)
|
—
|
|
(130
|
)
|
(7,713
|
)
|
|||||
Non-cash and other adjustments
|
—
|
|
2,039
|
|
(15,216
|
)
|
59
|
|
(13,118
|
)
|
|||||
Balance at September 27, 2019
|
$
|
128
|
|
$
|
15,723
|
|
$
|
—
|
|
$
|
—
|
|
$
|
15,851
|
|
|
Severance and associated costs
|
||
Restructuring charges
|
$
|
12,856
|
|
Cash payments
|
(168
|
)
|
|
Non-cash and other adjustments
|
—
|
|
|
Balance at September 29, 2017
|
$
|
12,688
|
|
Restructuring charges
|
23
|
|
|
Cash payments
|
(12,005
|
)
|
|
Non-cash and other adjustments
|
(582
|
)
|
|
Balance at September 28, 2018
|
$
|
124
|
|
|
Payments Due By Fiscal Period
|
||||||||||||||||||||
|
Fiscal
2020 |
Fiscal
2021 |
Fiscal
2022 |
Fiscal
2023 |
Fiscal
2024 |
Thereafter
|
Total
|
||||||||||||||
Naming rights
|
$
|
7,909
|
|
$
|
8,008
|
|
$
|
8,108
|
|
$
|
8,209
|
|
$
|
8,312
|
|
$
|
70,344
|
|
$
|
110,890
|
|
Operating leases
|
17,231
|
|
9,329
|
|
7,191
|
|
6,218
|
|
4,499
|
|
12,355
|
|
56,823
|
|
|||||||
Purchase obligations
|
37,675
|
|
4,241
|
|
1,803
|
|
—
|
|
—
|
|
—
|
|
43,719
|
|
|||||||
Donation commitments
|
4,243
|
|
141
|
|
141
|
|
141
|
|
141
|
|
1,059
|
|
5,866
|
|
|||||||
Total
|
$
|
67,058
|
|
$
|
21,719
|
|
$
|
17,243
|
|
$
|
14,568
|
|
$
|
12,952
|
|
$
|
83,758
|
|
$
|
217,298
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Total rent expense
|
$
|
20,589
|
|
$
|
17,161
|
|
$
|
15,091
|
|
|
Fiscal Year Ended
|
||||||||
Location
|
September 27,
2019 |
September 28, 2018
(as adjusted)
|
September 29, 2017
(as adjusted)
|
||||||
United States
|
$
|
449,203
|
|
$
|
353,235
|
|
$
|
377,553
|
|
International
|
792,417
|
|
701,365
|
|
702,624
|
|
|||
Total revenue
|
$
|
1,241,620
|
|
$
|
1,054,600
|
|
$
|
1,080,177
|
|
|
Fiscal Year Ended
|
|||||
Location
|
September 27,
2019 |
September 28, 2018
(as adjusted) |
September 29, 2017
(as adjusted) |
|||
United States
|
36
|
%
|
33
|
%
|
35
|
%
|
South Korea
|
12
|
%
|
17
|
%
|
13
|
%
|
China
|
20
|
%
|
15
|
%
|
20
|
%
|
Japan
|
11
|
%
|
13
|
%
|
12
|
%
|
Europe
|
12
|
%
|
12
|
%
|
10
|
%
|
Taiwan
|
4
|
%
|
3
|
%
|
4
|
%
|
Other
|
5
|
%
|
7
|
%
|
6
|
%
|
Total
|
100
|
%
|
100
|
%
|
100
|
%
|
Location
|
September 27,
2019 |
September 28,
2018 |
||||
United States
|
$
|
460,370
|
|
$
|
453,336
|
|
International
|
77,062
|
|
60,846
|
|
||
Total long-lived tangible assets, net of accumulated depreciation
|
$
|
537,432
|
|
$
|
514,182
|
|
Entity Name
|
Minority Ownership Interest
|
Location Of Properties
|
|
Dolby Properties Brisbane, LLC
|
49.0
|
%
|
Brisbane, California
|
Dolby Properties Burbank, LLC
|
49.0
|
%
|
Burbank, California
|
Dolby Properties, LP
|
10.0
|
%
|
Wootton Bassett, England
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Related party rent expense and restructuring charges included in operating expenses
|
$
|
16,360
|
|
$
|
3,483
|
|
$
|
3,142
|
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Distributions to principal stockholder
|
$
|
(1,015
|
)
|
$
|
(1,022
|
)
|
$
|
(2,094
|
)
|
|
Fiscal Year Ended
|
||||||||
|
September 27,
2019 |
September 28,
2018 |
September 29,
2017 |
||||||
Retirement plan expenses
|
$
|
23,375
|
|
$
|
23,439
|
|
$
|
22,035
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018 (as adjusted)
|
||||||||||||||||||||||
|
Q1
|
Q2
|
Q3
|
Q4
|
|
Q1
|
Q2
|
Q3
|
Q4
|
||||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Licensing
|
$
|
260,279
|
|
$
|
310,308
|
|
$
|
271,897
|
|
$
|
264,796
|
|
|
$
|
270,172
|
|
$
|
272,135
|
|
$
|
183,771
|
|
$
|
214,699
|
|
Products and services
|
42,097
|
|
27,950
|
|
30,262
|
|
34,031
|
|
|
29,355
|
|
27,587
|
|
31,009
|
|
25,872
|
|
||||||||
Total revenue
|
302,376
|
|
338,258
|
|
302,159
|
|
298,827
|
|
|
299,527
|
|
299,722
|
|
214,780
|
|
240,571
|
|
||||||||
Cost of revenue
|
38,629
|
|
36,575
|
|
39,690
|
|
45,960
|
|
|
30,893
|
|
31,027
|
|
34,383
|
|
31,259
|
|
||||||||
Gross margin
|
263,747
|
|
301,683
|
|
262,469
|
|
252,867
|
|
|
268,634
|
|
268,695
|
|
180,397
|
|
209,312
|
|
||||||||
Income/(loss) before taxes and controlling interest
|
74,254
|
|
110,002
|
|
41,800
|
|
56,251
|
|
|
96,547
|
|
87,782
|
|
(5,808
|
)
|
17,853
|
|
||||||||
Net income/(loss) attributable to Dolby Laboratories
|
$
|
98,219
|
|
$
|
73,440
|
|
$
|
39,574
|
|
$
|
43,918
|
|
|
$
|
(53,302
|
)
|
$
|
65,216
|
|
$
|
3,116
|
|
$
|
26,716
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Earnings per share:
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Basic
|
$
|
0.96
|
|
$
|
0.72
|
|
$
|
0.39
|
|
$
|
0.44
|
|
|
$
|
(0.52
|
)
|
$
|
0.63
|
|
$
|
0.03
|
|
$
|
0.26
|
|
Diluted
|
$
|
0.93
|
|
$
|
0.70
|
|
$
|
0.38
|
|
$
|
0.43
|
|
|
$
|
(0.52
|
)
|
$
|
0.61
|
|
$
|
0.03
|
|
$
|
0.25
|
|
Weighted-average shares outstanding:
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Basic
|
102,677
|
|
102,141
|
|
101,218
|
|
100,481
|
|
|
102,552
|
|
103,771
|
|
103,836
|
|
103,349
|
|
||||||||
Diluted
|
106,130
|
|
104,587
|
|
103,717
|
|
102,945
|
|
|
102,552
|
|
107,001
|
|
106,950
|
|
106,794
|
|
Executive Officers
|
Age
|
Position(s)
|
Kevin Yeaman
|
53
|
President and Chief Executive Officer
|
Lewis Chew
|
56
|
Executive Vice President and Chief Financial Officer
|
Andy Sherman
|
52
|
Executive Vice President, General Counsel and Corporate Secretary
|
Giles Baker
|
43
|
Senior Vice President, Consumer Entertainment
|
Steven Forshay
|
65
|
Senior Vice President, Advanced Technology Group
|
Todd Pendleton
|
47
|
Senior Vice President, and Chief Marketing Officer
|
1.
|
Financial Statements: See “Index to Consolidated Financial Statements” in Part II, Item 8 of this Annual Report on Form 10-K.
|
2.
|
Financial Statement Schedules: Financial statement schedules have been omitted as the information required is inapplicable or the information is presented in the consolidated financial statements and related notes
|
3.
|
Exhibits: The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Annual Report on Form 10-K.
|
DOLBY LABORATORIES, INC.
|
|
By:
|
/S/ LEWIS CHEW
|
|
Lewis Chew
|
|
Executive Vice President and Chief Financial Officer
|
|
(Principal Financial Officer)
|
SIGNATURE
|
|
TITLE
|
DATE
|
/S/ PETER GOTCHER
|
|
Chairman of the Board of Directors
|
November 22, 2019
|
Peter Gotcher
|
|
|
|
|
|
|
|
/S/ KEVIN J. YEAMAN
|
|
President, Chief Executive Officer and Director
(Principal Executive Officer)
|
November 22, 2019
|
Kevin J. Yeaman
|
|
|
|
|
|
|
|
/S/ LEWIS CHEW
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|
November 22, 2019
|
Lewis Chew
|
|
|
|
|
|
|
|
/S/ RYAN NICHOLSON
|
|
Vice President, Corporate Controller
(Principal Accounting Officer)
|
November 22, 2019
|
Ryan Nicholson
|
|
|
|
|
|
|
|
/S/ MICHELINE CHAU
|
|
Director
|
November 22, 2019
|
Micheline Chau
|
|
|
|
|
|
|
|
/S/ DAVID DOLBY
|
|
Director
|
November 22, 2019
|
David Dolby
|
|
|
|
|
|
|
|
/S/ N. W. JASPER, JR.
|
|
Director
|
November 22, 2019
|
N. W. Jasper, Jr.
|
|
|
|
|
|
|
|
/S/ SIMON SEGARS
|
|
Director
|
November 22, 2019
|
Simon Segars
|
|
|
|
|
|
|
|
/S/ ROGER SIBONI
|
|
Director
|
November 22, 2019
|
Roger Siboni
|
|
|
|
|
|
|
|
/S/ ANJALI SUD
|
|
Director
|
November 22, 2019
|
Anjali Sud
|
|
|
|
|
|
|
|
/S/ AVADIS TEVANIAN, JR.
|
|
Director
|
November 22, 2019
|
Avadis Tevanian, Jr.
|
|
|
|
•
|
500,000,000 shares are designated as Class A common stock; and
|
•
|
500,000,000 shares are designated as Class B common stock.
|
•
|
Holders of Class B common stock outstanding immediately following the effectiveness of our initial public offering (which occurred in February 2005), and the initial holders of shares of Class B common stock issued upon the exercise of options outstanding at such time, who we collectively refer to as our Class B holders;
|
•
|
Spouses or lineal descendants, or the spouses or domestic partners of such lineal descendants, of the Class B holders;
|
•
|
Executors or administrators of the estates of Class B holders, their spouses or lineal descendants, or the spouses or domestic partners of such lineal descendants;
|
•
|
Trusts for the benefit of Class B holders, their spouses or lineal descendants, the spouses or domestic partners of such lineal descendants, or the parents of the spouses or lineal descendants of Class B holders or the spouses or domestic partners of such lineal descendants, provided that the beneficiaries of such trusts may also include individuals or entities entitled to specific cash distributions or specific items of property other than shares of Class B common stock and charitable organizations;
|
•
|
Charitable organizations established by Class B holders, their spouses or lineal descendants, or the spouses or domestic partners of such lineal descendants; or
|
•
|
Any other entity controlled by Class B holders, their spouses or lineal descendants, or the spouses or domestic partners of such lineal descendants, or trusts for their benefit, or charitable organizations established by them.
|
•
|
The powers, preferences and rights of each class of common stock, including voting, dividend, liquidation and conversion rights;
|
•
|
The requirement that stockholders provide advance notice of matters to be acted upon and nominations for the election of directors at a stockholders meeting; and
|
•
|
The limits on the ability of stockholders to act by written consent or to call a special meeting.
|
•
|
The limits on the ability of stockholders to act by written consent or to call a special meeting;
|
•
|
The provision prohibiting cumulative voting for the election of directors; and
|
•
|
The requirement that stockholders provide advance notice of matters to be acted upon and nominations for the election of directors at a stockholders meeting.
|
•
|
Prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;
|
•
|
Upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned by persons who are directors and also officers, and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
|
•
|
At or subsequent to the date of the transaction, the business combination is approved by the board of directors and by the stockholders at an annual or special meeting, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.
|
Name
|
Jurisdiction of Incorporation/Organization
|
Dolby Laboratories, Inc.
|
California
|
Dolby Laboratories Licensing Corporation
|
New York
|
Dolby International AB
|
Sweden
|
1.
|
I have reviewed this Annual Report on Form 10-K of Dolby Laboratories, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ KEVIN J. YEAMAN
|
Kevin J. Yeaman
|
President and Chief Executive Officer
(Principal Executive Officer)
|
1.
|
I have reviewed this Annual Report on Form 10-K of Dolby Laboratories, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ LEWIS CHEW
|
Lewis Chew
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|
•
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
•
|
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ KEVIN J. YEAMAN
|
|
Kevin J. Yeaman
President and Chief Executive Officer (Principal Executive Officer)
|
|
|
|
/s/ LEWIS CHEW
|
|
Lewis Chew
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
|
|